CAS No. |
107000-34-0 |
|---|---|
中文名称 |
(1R,3aS,3bR,5aS,10aS,10bS,12aS)-1-乙炔基-10a,12a-二甲基-8-甲磺酰基-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-十六氢环戊并[5,6]萘并[1,2-f]吲唑-1-醇 |
英文名称 |
(1R,3aS,3bR,5aS,10aS,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-8-(methylsulfonyl)-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol |
别名 |
Zanoterone;17-Ethynyl-1'-(methylsulfonyl)-1'H-5α-androstano[3,2-c]pyrazole-17β-ol;17-Ethynyl-1'-methylsulfonyl-1'H-5α-androstano[3,2-c]pyrazole-17β-ol;17α-Ethynyl-1'-methylsulfonyl-1'H-5α-androsta-2-eno[3,2-c]pyrazole-17-ol;Win-49596;1'H-Pregn-20-yno[3,2-c]pyrazol-17-ol, 1'-(methylsulfonyl)-, (5α,17α)- |
标准英文名 |
(1R,3aS,3bR,5aS,10aS,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-8-(methylsulfonyl)-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol |
MDL No. |
MFCD00864667 |
分子式 |
C23H32N2O3S |
分子量 |
416.59 |
精确分子量 |
416.21 |
SMILES |
C#C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC5=NN(S(C)(=O)=O)C=C5C[C@]4(C)[C@H]3CC[C@@]21C |
标准SMILES |
C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC5=NN(C=C5C[C@@]43C)S(C)(=O)=O)[C@@H]1CC[C@@]2(O)C#C |
用途 |
Zanoterone is an orally active androgen receptor (AR) antagonist (Ki = 2.2 μM) that blocks the binding of androgens such as testosterone and dihydrotestosterone (DHT), thereby inhibiting androgen signaling pathways and reducing the growth of androgen-dependent benign prostatic hyperplasia and prostate cancer. |
InChIKey |
MHDDZDPNIDVLNK-ZGIWMXSJSA-N |
|
|
评论 |
|---|